NasdaqHealth CareHealth Care EquipmentS&P SmallCap 600
$7.33
-0.08 (-1.08%)
Close of Nov 06, 2026 · end-of-day data
AHCO 8-K filings in 2024
Every material Form 8-K AdaptHealth filed with the SEC in 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
On December 9, 2024, AdaptHealth amended the transition, separation and release agreement with Shaw Rietkerk, its Chief Business Officer, reducing his annual base salary from $500,000 to $125,000 starting January 1, 2025. The filing describes a compensation change for one officer and does not state any effect on the company's financial results.
Amendment dated December 9, 2024, to a transition, separation and release agreement dated August 21, 2024
Annual base salary reduced from $500,000 to $125,000, effective January 1, 2025
Full amendment filed as Exhibit 10.1; the 8-K was signed by CFO Jason Clemens on December 13, 2024
AdaptHealth reported third-quarter 2024 net revenue of $805.9 million, up 0.2%, and net income attributable to the company of $22.9 million, compared with a net loss of $454.1 million a year earlier. The company lowered its 2024 net revenue and adjusted EBITDA guidance while raising its free cash flow guidance, so results and outlook point in different directions for shareholders.
Net revenue was $805.9 million versus $804.0 million, and adjusted EBITDA was $164.3 million versus $161.2 million, up 1.9%.
Net income attributable to AdaptHealth was $22.9 million, compared with a net loss of $454.1 million in the prior-year quarter, which included a $511.9 million goodwill impairment.
2024 net revenue guidance was lowered to $3.220 billion to $3.260 billion from $3.255 billion to $3.315 billion.
2024 adjusted EBITDA guidance was lowered to $655 million to $675 million from $660 million to $700 million; free cash flow guidance was raised to $175 million to $195 million from $160 million to $180 million.
AdaptHealth Corp. entered into a new employment agreement with Chief Technology Officer Albert Prast on October 30, 2024, superseding his July 24, 2023 agreement. The filing sets a $450,000 base salary, a target bonus of 100% of base salary, and severance terms if he is terminated without cause or resigns for good reason. The filing contains no financial results, and the terms are a routine compensation update for a senior officer.
Base salary of $450,000 with a target annual bonus equal to 100% of base salary
Severance on a qualifying termination includes 18 months of base salary continuation and up to 18 months of COBRA health coverage
Equity awards eligible from 2025 under the Second Amended and Restated 2019 Stock Incentive Plan
Non-compete applies for 18 months after employment ends; non-solicit for 24 months
AdaptHealth Corp. appointed Diana L. Nole to its Board of Directors effective October 16, 2024, as a Class I director, and the Board has determined she is independent under SEC and Nasdaq rules. Ms. Nole previously served as Executive Vice President and General Manager of the Healthcare Division of Nuance Communications, and the appointment adds a director with healthcare technology experience to the Board.
Diana L. Nole, age 59, appointed to the Board effective October 16, 2024; term runs until the 2026 annual meeting
Served as EVP and General Manager of Nuance Communications' Healthcare Division from June 1, 2020 to October 4, 2024
Company entered into an indemnification agreement with Ms. Nole on October 16, 2024; she receives the same non-employee director compensation, pro-rated for the current year
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every AdaptHealth filing is on SEC EDGAR ↗. 8-K briefs of other companies →